ANI Pharmaceuticals to Discuss First Quarter 2021 Financial Results on May 7, 2021
April 26 2021 - 4:30PM
Business Wire
ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ:
ANIP) today announced that the Company will release its first
quarter 2021 financial results on Friday, May 7, 2021.
Nikhil Lalwani, President and Chief Executive Officer, and
Stephen P. Carey, Senior Vice President, Finance, and Chief
Financial Officer, will host a conference call to discuss the
results as follows:
Date
Friday, May 7, 2021
Time
8:30 a.m. ET
Toll free (U.S.)
866-518-6930
Webcast (live and replay)
www.anipharmaceuticals.com, under the
“Investors” section
A replay of the conference call will be available within two
hours of the call’s completion and will remain accessible for
one-week by dialing 800-934-5153 and entering access code
5412658.
About ANI
ANI Pharmaceuticals, Inc. is an integrated specialty
pharmaceutical company focused on delivering value to our customers
by developing, manufacturing, and marketing high quality branded
and generic prescription pharmaceuticals. We focus on niche and
high barrier to entry opportunities including controlled
substances, oncology products (anti-cancer), hormones and steroids,
and complex formulations. For more information, please visit our
website www.anipharmaceuticals.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210426005658/en/
Investor Relations: Lisa M. Wilson, In-Site Communications, Inc.
T: 212-452-2793 E: lwilson@insitecony.com
ANI Pharmaceuticals (NASDAQ:ANIP)
Historical Stock Chart
From Aug 2024 to Sep 2024
ANI Pharmaceuticals (NASDAQ:ANIP)
Historical Stock Chart
From Sep 2023 to Sep 2024